Protalix BioTherapeutics (PLX) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,347.00 |
| Dec 31, 2025 | 1,446.00 |
| Sep 30, 2025 | 353.00 |
| Jun 30, 2025 | 688.00 |
| Mar 31, 2025 | 1,235.00 |
| Dec 31, 2024 | 12,354.00 |
| Sep 30, 2024 | 6,135.00 |
| Jun 30, 2024 | 1,323.00 |
| Mar 31, 2024 | 8,279.00 |
| Dec 31, 2023 | 7,654.00 |
| Sep 30, 2023 | 12,612.00 |
| Jun 30, 2023 | 11,460.00 |
| Mar 31, 2023 | 6,290.00 |
| Dec 31, 2022 | 6,596.00 |
| Sep 30, 2022 | 3,408.00 |
| Jun 30, 2022 | 2,560.00 |
| Mar 31, 2022 | 360.00 |
| Dec 31, 2021 | 28,170.00 |
| Sep 30, 2021 | 2,751.00 |
| Jun 30, 2021 | -9,378.00 |
| Mar 31, 2021 | -9,484.00 |
| Mar 31, 2019 | -1,358.00 |
| Dec 31, 2018 | -1,308.00 |
| Sep 30, 2018 | -3,251.00 |
| Jun 30, 2018 | -505.00 |
| Mar 31, 2018 | -5,398.00 |
| Dec 31, 2017 | -5,538.00 |
| Sep 30, 2017 | -8,267.00 |
| Jun 30, 2017 | -4,470.00 |
| Mar 31, 2017 | 3,277.00 |
| Dec 31, 2016 | -22,968.00 |
| Sep 30, 2016 | 2,605.00 |